ISIS Pharmaceuticals (ISIS): Q4 EPS of -$0.20 misses by $0.07. Revenue of $32.4M (+22.7% Y/Y)...

|By:, SA News Editor
ISIS Pharmaceuticals (ISIS): Q4 EPS of -$0.20 misses by $0.07. Revenue of $32.4M (+22.7% Y/Y) beats by $2M. (PR)